Roche announced that new data from its Alzheimer’s development portfolio is being presented at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada (July 27-30). These data ...

The North America Autoimmune Disease Diagnostics Market is projected to grow from USD 1.96 billion in 2024 to USD 3.5 billion by 2033, at a CAGR of 6.66%. Key growth drivers include rising ...

Late-breaking oral and poster presentations highlight the potential of Roche’s Elecsys® pTau217 as a reliable and accessible blood-based biomarker test, providing comparable results to PET scan and ...

Late-breaking oral and poster presentations highlight the potential of Roche’s Elecsys® pTau217 as a reliable and accessible blood-based biomarker test, providing comparable results to PET scan and ...

Late-breaking oral and poster presentations highlight the potential of Roche’s Elecsys ® pTau217 as a reliable and accessible blood-based biomarker test, providing comparable results to PET scan and ...

See how Roche’s trontinemab and pTau217 blood test could revolutionize Alzheimer’s care. Discover early detection tools and new trial data today.

Roche (SIX: RO, ROG; OTCQX: RHHBY) will showcase its science-driven leadership in diagnostics at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Scientific Meeting and Clinical Lab ...

Visit Roche Diagnostics at Booth 1902 to explore how our solutions bring science to life, simplify operations and elevate diagnostic excellence for patients worldwide.

Roche (SIX: RO, ROG; OTCQX: RHHBY) will showcase its science-driven leadership in diagnostics at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Scientific Meeting and Clinical ...

As Africa marks World Blood Donor Day on June 14, 2025, Dr Allan Pamba, Executive Vice President for Diagnostics, Africa at Roche Diagnostics is calling for urgent investment in blood systems and ...

Roche Diagnostics, a global pioneer in pharmaceuticals and diagnostics, has expanded its operations in Nigeria, reinforcing its commitment to expanding access to high-quality diagnostics across ...

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of ...